Difference between revisions of "Reed Elsevier"
Jump to navigation
Jump to search
Josh Leeson (talk | contribs) |
Josh Leeson (talk | contribs) |
||
| Line 9: | Line 9: | ||
==Lobbying firms== | ==Lobbying firms== | ||
| + | *[[Incisive Health]]<ref> Incisive Health [http://www.incisivehealth.com/clients Clients], accessed 25 June 2015.</ref> | ||
*[[Finsbury]]<ref> [http://www.prca.org.uk/assets/files/Consultancy%20Register%20Sept-Nov%202014%20pdf(1).pdf Agency Register September to November 2014] ''PRCA'', accessed 29 January 2015 </ref> | *[[Finsbury]]<ref> [http://www.prca.org.uk/assets/files/Consultancy%20Register%20Sept-Nov%202014%20pdf(1).pdf Agency Register September to November 2014] ''PRCA'', accessed 29 January 2015 </ref> | ||
Latest revision as of 15:01, 25 June 2015
Reed Elsevier' is a publisher and information provider operating in the science, medical, legal, risk and business sectors. It is listed on several of the world's major stock exchanges. It is a FTSE 100 and FT Global 500 company. The Reed Elsevier group is a dual-listed company consisting of Reed Elsevier PLC and Reed Elsevier NV.[1]
Divisions
- The science and medical publishing division is Elsevier.
- The risk division is LexisNexis Risk Solutions.
- The legal publishing division is LexisNexis Legal & Professional. LexisNexis combines Butterworths, Tolley, LexisNexis, Visualfiles, and InterAction and services clients in law, tax & accounting, corporations, public sector, academic institutions and risk and compliance.
- The exhibitions division is Reed Exhibitions.
- The business division is Reed Business Information
Lobbying firms
EU Lobbying
Reed Elsevier have 2 lobbyists with European Parliament passes, allowing the bearer virtually unlimited access to the Parliament's buildings.[4]
Notes
- ↑ Reed-Elsevier corporate structure
- ↑ Incisive Health Clients, accessed 25 June 2015.
- ↑ Agency Register September to November 2014 PRCA, accessed 29 January 2015
- ↑ Companies declaring the most lobbyists Lobby Facts, 26 January 2015, accessed 3 February 2015